RAS is the second major mutant gene in melanoma and the co-occurrence frequency with CCND1 amplification was 1.32% (4/302), 1.63% (6/367), and 0.86% (3/350) among the Geneplus, TCGA, and MSKCC cohorts, respectively. Here, CCND1 is linked to melanoma.